February 12, 2026
  • Facebook
  • Twitter
  • LinkedIn

BiomolBiomed Viewpoints

Science in plain words

  • Home
  • News
  • About
    • BiomolBiomed Viewpoints
    • BiomolBiomed Journal
  • Journal Website
  • Reviews
  • pathology
  • microbiology
  • immunology
  • translational medicine
  • genetics
  • biochemistry
  • anatomy
  • molecular biology
  • clinical medicine
  • new methods
  • new medical entities
Latest posts
  • [ February 11, 2026 ] Thank You to Our 2025 Reviewers News
  • [ December 29, 2025 ] Induced Sputum KL-6 and HRCT Scoring in Idiopathic Pulmonary Fibrosis Author Summary
  • [ December 26, 2025 ] Prof. Luca Testarelli: Bridging Restorative Dentistry, Endodontics and Digital Innovation Interview
  • [ December 26, 2025 ] SHR and SIRI Improve CHD Detection in Type 2 Diabetes Author Summary
  • [ December 24, 2025 ] IRF5 Variants Linked to Rheumatoid Arthritis Risk in Mexican Women Author Summary
Homesorafenib

sorafenib

TCF12 Enhances Liver Cancer Angiogenesis and Drug Response via HIF-1α
Author Summary

TCF12 Enhances Liver Cancer Angiogenesis and Drug Response via HIF-1α

June 4, 2025 0

A new study reveals how the transcription factor TCF12 promotes angiogenesis and limits the effectiveness of sorafenib in liver cancer by stabilizing HIF-1α. Understanding Liver Cancer and Its Treatment Challenges Liver cancer remains one of […]

BiomolBiomed journal metrics

  • Impact Factor 2024 (JCR®): 2.2
  • CiteScore 2024 (Scopus): 5.2
  • Google Scholar Citations
  • Dimensions metrics

See more here…

BiomolBiomed Newsletters

Subscribe to receive the latest content and news from Biomolecules and Biomedicine. Choose from our sections or themes of your interest.

Categories

  • Author Summary
  • Conferences
  • Interview
  • News
  • Opinion
  • Reviewer of the Month
  • Topics
  • Video Summary

Archives

TELL US

What matters the most when choosing the journal to submit your article?
Vote
Follow us on Facebook

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH

 

Loading Comments...